bupropion hydrochloride sr (63187-726)

Drug Facts

Product Profile

Brand Name bupropion hydrochloride sr

Generic Name bupropion hydrochloride

Labeler proficient rx lp

Dosage Form TABLET, FILM COATED, EXTENDED RELEASE

Routes

ORAL

Active Ingredients

bupropion hydrochloride 150 mg/1

Manufacturer

Proficient Rx LP

Identifiers & Regulatory

Product NDC 63187-726

Product ID 63187-726_d2ba7af1-c874-47ab-b638-be94dfe1b1dd

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA079095

Listing Expiration 2026-12-31

Marketing Start 2009-07-02

Pharmacologic Class

Classes

aminoketone [epc] dopamine uptake inhibitors [moa] increased dopamine activity [pe] increased norepinephrine activity [pe] norepinephrine uptake inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63187726

Hyphenated Format 63187-726

Supplemental Identifiers

RxCUI

993518

UPC

0363187726300

UNII

ZG7E5POY8O

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupropion hydrochloride sr (source: ndc)

Generic Name bupropion hydrochloride (source: ndc)

Application Number ANDA079095 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

150 mg/1

source: ndc

Packaging

30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-30)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-60)
90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-90)

source: ndc

Packages (3)

63187-726-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-30) 63187-726-60 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-60) 63187-726-90 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-90)

Ingredients (1)

bupropion hydrochloride (150 mg/1)

Linked Drug Pages (1)

Bupropion Hydrochloride SR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "d2ba7af1-c874-47ab-b638-be94dfe1b1dd", "openfda": {"upc": ["0363187726300"], "unii": ["ZG7E5POY8O"], "rxcui": ["993518"], "spl_set_id": ["13770e60-117c-4814-93bb-9bc41a042a20"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-30)", "package_ndc": "63187-726-30", "marketing_start_date": "20160701"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-60)", "package_ndc": "63187-726-60", "marketing_start_date": "20160701"}, {"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (63187-726-90)", "package_ndc": "63187-726-90", "marketing_start_date": "20160701"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "63187-726_d2ba7af1-c874-47ab-b638-be94dfe1b1dd", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "63187-726", "generic_name": "bupropion hydrochloride", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA079095", "marketing_category": "ANDA", "marketing_start_date": "20090702", "listing_expiration_date": "20261231"}